Studies In Follow Up




All Heart Study

New patient recruitment to this study finished in September 2017

The study continues with all patients now in the follow up stage (the follow-up processes are remote with no face-to-face contact) - we would like to thank patients for their continuing participation.

Allopurinol is a medication usually used to prevent gout - it has several positive effects on the heart and blood vessels, is inexpensive and is already widely used in patients. Ischaemic heart disease is common in people in the UK.

In this study, we want to improve the treatment of patients with ischaemic heart disease by investigating whether adding allopurinol to these patients’ usual medications will reduce their risk of having a stroke, heart attack or of dying due to cardiovascular disease.


Renewed Online

A resource 'renewed online' which supports people who have finished treatment for breast, bowel or prostate cancer, or people on active surveillance. There is advice on improving physical health and help with feelings of tiredness or stress and concerns about cancer.


Virus Watch Study

The Virus Watch Study is an Urgent Public Health Study they are looking for households to join and help them understand how Covid-19 acts and spreads.

Virus Watch results are proving vital in informing government planning, public health and NHS responses to Covid-19.

Please click here to read about the early preliminary findings from the team

Find out more about Renewed Online here



The study team would like to see whether giving personal feedback to people with depression, or low mood, can help them to get better more quickly.  If you have attended the surgery for low mood or depression you may be given an information pack by the clinician seeing you, or we may send an information pack out to you.

For more information about the PROMDEP Study click here



The REDUCE Study aims to help people on long-term antidepressants reduce the dose of their antidepressant one step at a time, over some weeks or months, and eventually stop taking it altogether if appropriate. This would be led and supported by your GP (or nurse prescriber), and you would have follow-up appointments for support and monitoring for any withdrawal symptoms or recurrence of depression.

For more information about the REDUCE Study click here